This Family Office Acquired $148 Million of Karman Stock as Shares Tripled Since February IPO

Schusterman Interests disclosed a new position in Karman Holdings in an 11/14 13F filing, acquiring nearly 2.1 million shares valued at $148 million as of Sept. 30, making Karman the fund’s largest single equity holding (33.8% of reported assets). Karman shares traded at $67.03 (versus a $22 IPO price in February), with reported metrics including a $7.97 billion market cap, $428.2 million revenue (TTM) and $11.3 million net income (TTM). The concentrated, thesis-driven family office bet underscores institutional interest in newly public aerospace/defense suppliers and may influence investor perception of Karman’s early post-IPO trajectory.

Analysis

Market structure: Schusterman’s $148M block materially signals institutional conviction for KRMN and should mechanically lift small-cap aerospace peers and specialized suppliers (titanium/rare-alloy vendors) via sentiment flows; losers are late-cycle or commodity-dependent suppliers with weaker program exposure. The move increases idiosyncratic liquidity for KRMN and likely raises call interest and implied-volatility skew for near-term options; commodities impact is concentrated — upward pressure on specialty metals not broad oil/FX moves.

Risk assessment: Key tail risks are DoD budget re-prioritization, program cancellations, ITAR/export constraints, or a large secondary offering that dilutes current holders; KRMN trades at ~18.6x P/S (7.97B/428M) with net margin ~2.6%, so earnings misses could trigger 30–50% re-rating. Immediate (days) risk: momentum reversal of 15–35% on block-news fade; short-term (weeks–months): contract awards or quarterly updates can move stock >30%; long-term hinges on sustaining 20–30%+ CAGR and margin expansion to mid-teens to justify current market cap.

Trade implications: Direct: establish a starter long (1–2% portfolio) in KRMN on pullbacks to $55–60 and scale to 3% only after two consecutive quarters of backlog-to-revenue conversion. Use 3–6 month call spreads (buy $65/$85 for limited cost) or sell 2‑to‑1 put spreads (sell $55/$45) to collect premium if willing to own below $55. Pair: long KRMN / short XAR (equal notional, reduce sector beta) to express idiosyncratic upside while hedging A&D cyclicality.

Contrarian angles: Consensus underestimates capital intensity and the risk that current valuation prices >30% CAGR and margin expansion; if growth slows below 20% or margin stays <5%, multiple compression of 40%+ is plausible. Historical parallels (early aerospace IPOs like Rocket Lab/AJRD) show big initial pops followed by mean reversion; another hidden risk is Schusterman’s concentrated 33.8% equity weighting in its reported book — an eventual rebalancing could create meaningful supply over 3–12 months.

Key Decisions for Investors

• Initiate a tactical long in KRMN equal to 1–2% of portfolio on a pullback to $55–60; add to 3% only after two consecutive quarters showing backlog conversion and +20% YoY revenue growth.
• Buy 3–6 month KRMN call spreads (buy $65 / sell $85) sized to cap max loss at 1% of portfolio — objective: capture momentum with defined downside if stock retests $55.
• Construct a directional pair: long KRMN (notional $1) / short XAR (notional $0.8) to isolate KRMN idiosyncratic upside while hedging sector beta; rebalance monthly and trim if KRMN > $80 or XAR outperforms by >15% in 30 days.
• Sell a put spread to accrue yield if willing to own: sell KRMN $55 puts and buy $45 puts (90–180 day) sized such that assignment results in a 1–2% portfolio position at effective cost <= $50/share; avoid if DoD budget hearings within 30 days indicate risk of cuts.